Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved the 2026 Stock Incentive Plan at the June 4, 2026 annual meeting.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved the 2026 Stock Incentive Plan at the June 4, 2026 annual meeting
- 2,500,000 shares initially available for equity awards, plus certain recycled 2019 Plan shares
- 2026 Plan becomes effective October 16, 2026, when the 2019 Plan expires
- Expanded equity authorization supports employee retention but creates potential shareholder dilution
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All nine director nominees elected through 2027 Annual Meeting, preserving board continuity
- Series A holders exclusively elected Jason Aryeh and Christopher Kiper, highlighting preferred-stock governance influence
- KPMG appointment ratified overwhelmingly, supporting auditor continuity for 2026
- Executive compensation approved 22.94M–178,868 in advisory vote, indicating strong shareholder support
- 2026 Stock Incentive Plan approved 22.72M–392,825, enabling additional equity-based compensation flexibility
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.